Unknown

Dataset Information

0

Variation in therapeutic strategies for the management of severe COVID-19 in India: A nationwide cross-sectional survey.


ABSTRACT:

Aim

During the pandemic of coronavirus disease 2019 (COVID-19), the physicians are using various off-label therapeutics to manage COVID-19. We undertook a cross-sectional survey to study the current variation in therapeutic strategies for managing severe COVID-19 in India.

Methods

From January 4 to January 18, 2021, an online cross-sectional survey was conducted among physicians involved in the management of severe COVID-19. The survey had three sections: 1. Antiviral agents, 2. Immunomodulators, and 3. Adjuvant therapies.

Results

1055 respondents (from 24 states and five union territories), of which 64.2% were consultants, 54.3% working in private hospitals, and 39.1% were from critical care medicine completed the survey. Remdesivir (95.2%), antithrombotics (94.2%), corticosteroids (90.3%), vitamins (89.7%) and empirical antibiotics (85.6%) were the commonly used therapeutics. Ivermectin (33%), convalescent plasma (28.6%) and favipiravir (17.6%) were other antiviral agents used. Methylprednisolone (50.2%) and dexamethasone (44.1%) were preferred corticosteroids and at a dose equivalent of 8 mg of dexamethasone phosphate (70.2%). There was significant variation among physicians from different medical specialities in the use of favipiravir, corticosteroids, empirical antibiotics and vitamins.

Conclusion

There is a considerable variation in the physicians' choice of therapeutic strategies for the management of severe COVID-19 in India, as compared with the available evidence.

SUBMITTER: Jagiasi B 

PROVIDER: S-EPMC8420329 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC5496264 | biostudies-literature
| S-EPMC3358626 | biostudies-literature
| S-EPMC8612128 | biostudies-literature
| S-EPMC9304998 | biostudies-literature
| S-EPMC6565360 | biostudies-literature
| S-EPMC8671730 | biostudies-literature
| S-EPMC4021187 | biostudies-other
| S-EPMC4677188 | biostudies-literature
| S-EPMC8343210 | biostudies-literature
| S-EPMC7549465 | biostudies-literature